Concepedia

Doris K. Robbins

DK

5

Publications

129

Citations

5

H-Index

1992

Active since

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (Canada)

IQVIA (United States)

Doris K. Robbins is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1992–2001

5

Publications

5

Dose proportionality and comparison of single and multiple dose pharmacokinetics of fexofenadine (MDL 16 455) and its enantiomers in healthy male volunteers

Doris K. Robbins, MARK CASTLES, David Pack et al. · Biopharmaceutics & Drug Disposition · 1998 · 71 citations

Effect of Alosetron on the Pharmacokinetics of Alprazolam

Doreen L. D'Souza, Laurence M. Levasseur, James Nezamis et al. · The Journal of Clinical Pharmacology · 2001 · 19 citations

Effect of Alosetron on the Pharmacokinetics of Fluoxetine

Doreen L. D'Souza, Dan C. Dimmitt, Doris K. Robbins et al. · The Journal of Clinical Pharmacology · 2001 · 16 citations

Interaction of valproic acid and some analogues with microsomal epoxide hydrolase

Doris K. Robbins, Peter J. Wedlund, Sabine Elsberg et al. · Biochemical Pharmacology · 1992 · 12 citations

, , +8

PHARMACOKINETICS OF MDL 26 479, A NOVEL BENZODIAZEPINE INVERSE AGONIST, IN NORMAL VOLUNTEERS

Doris K. Robbins, Sam J. Hutcheson, TERRY D. MILLER et al. · Biopharmaceutics & Drug Disposition · 1997 · 11 citations

, , +14

Rows per page

1–5 of 5